Diagnostic and prognostic significance of survivin levels in malignant pleural effusion

Respiratory Medicine

Volumn 107, Issue 8, 2013, Pages 1260-1265

  Görgün, Didem ^a   Seçik, Funda ^a   Midilli, Kenan ^b   Akkaya, Vakur ^c   Yildiz, Pinar ^a  

^a Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Malignant; Pleural effusion; Prognosis; Survivin

Indexed keywords

ALBUMIN; DIURETIC AGENT; GLUCOSE; PROTEIN; SURVIVIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DIURETIC THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PLEURA DISEASE; PLEURA EFFUSION; PLEURA FLUID; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TRANSUDATIVE PLEURA EFFUSION; TUBERCULOSIS; TUBERCULOUS PLEURISY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 84880786510     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.04.011     Document Type: Article

References (20)

1. C.M. Burrows, W.C. Mathews, and H.G. Colt Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease Chest 117 2000 73 78 (Pubitemid 30053623)
2. D. Morgensztern, S. Waqar, and J. Subramanian Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer J Thorac Oncol 7 10 2012 Oct 1485 1489
3. E.A. Rakha, S. Patil, and K. Abdulla The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma Diagn Cytopathol 38 12 2010 874 879
4. M.V. Brock, C.M. Hooker, and R. Yung Can we improve the cytologic examination of malignant pleural effusions using molecular analysis? Ann Thorac Surg 80 4 2005 1241 1247 (Pubitemid 41354096)
5. E.T. Shinohara, A. Gonzalez, and P.P. Massion Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma Cancer 103 8 2005 1685 1692 (Pubitemid 40490030)
6. D.N. Church, and D.C. Talbot Survivin in solid tumors: rationale for development of inhibitors Curr Oncol Rep 14 2 2012 120 128
7. B. Nachmias, Y. Ashhab, and D. Ben-Yehuda The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer Semin Cancer Biol 14 4 2004 231 243 (Pubitemid 38824584)
8. D.C. Altieri Validating survivin as a cancer therapeutic target Nat Rev Cancer 3 2003 46 54 (Pubitemid 37328886)
9. U. Warnecke-Eberz, S.E. Baldus, and E. Bollschweiler Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis Anticancer Res 28 3A 2008 1525 1529 (Pubitemid 351892925)
10. L. Kleinberg, A.K. Lie, and V.A. Flørenes Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma Hum Pathol 38 7 2007 986 994 (Pubitemid 46899149)
11. D.Q. Dong, Y.H. Yang, and D.Y. Xue Expression of survivin mRNA of sputum and pleural effusions in human lung cancer Zhong Nan Da Xue Xue Bao Yi Xue Ban 31 6 2006 848 852
12. C.C. Lan, Y.K. Wu, and C.H. Lee Increased survivin mRNA in malignant pleural effusion is significantly correlated with survival Jpn J Clin Oncol 40 3 2010 234 240
13. D.S. Park, K.E. Hwang, and H. Shim Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions Clin Exp Metastasis 29 2012 83 89
14. X. Wang, L. Huang, and Y. Xu Association between survivin -31G>C promoter polymorphism and cancer risk: a meta-analysis Eur J Hum Genet. 20 7 2012 790 795
15. W. Naumnik, W. Nilklińska, and M. Ossolińska Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy Folia Histochem Cytobiol. 47 4 2009 703 709
16. D. Derin, H.O. Soydinç, and N. Guney Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer Lung Cancer 59 2 2008 240 245 (Pubitemid 351173407)
17. S.D. Smith, M.A. Wheeler, and J. Plescia Urine detection of survivin and diagnosis of bladder cancer JAMA 285 3 2001 324 328 (Pubitemid 32095036)
18. Y.K. Wu, K.T. Chen, and Y.B. Kuo Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer Cancer Lett 273 2 2009 331 335
19. E. Giroux Leprieur, A. Lavole, and A.M. Ruppert Factors associated with long-term survival of patients with advanced non-small cell lung cancer Respirology 17 1 2012 134 142
20. F. Altznauer, S. Martinelli, and S. Yousefi Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils J Exp Med 199 2004 1343 1354 (Pubitemid 38685726)